Chinese company starts mass producing Gilead coronavirus drug

05:10 EST 12 Feb 2020 | Pharmafile

A drugmaker in China said it has started mass producing Gilead Sciences Ebola drug that has the potential to fight the coronavirus.

It will be developed by BrightGene Bio-Medical Technology. They said in a statement, filed to the Shanghai Stock Exchange,it has the technology to synthesize the active pharmaceutical ingredients of remdesivir, Gilead’s drug that is a leading candidate to treat the coronavirus.

read more

Original Article: Chinese company starts mass producing Gilead coronavirus drug


More From BioPortfolio on "Chinese company starts mass producing Gilead coronavirus drug"

Quick Search

Relevant Topics

Marburg and Ebola Virus Infections
Ebola virus and Marburg virus are related viruses that cause hemorrhagic fevers — illnesses marked by severe bleeding (hemorrhage), organ failure and, in many cases, death. Both viruses are native to Africa, where sporadic outbreaks have occurred f...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...